课题基金 / 基金详情

Processing of HBsAg expressed by variceela-zosten virus

Processing of HBsAg expressed by variceela-zosten virus
水痘病毒表达的 HBsAg 的加工
批准号:
04454199
负责人:
SHIRAKI Kimiyasu
金额:
$0.58万
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (B)
财政年份:
1992
资助国家:
日本
项目状态:
已结题
起止时间:
1992 至 1993

项目摘要

项目成果

SHIRAKI Kimiyasu的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Hepatitis B surface antigen (HBsAg) was expressed by varicella-zoster virus (VZV) and morphogenesis of expressed HBsAg particles was studied by using metabolic inhibitors. HBsAg was modified by N-linked and O-linked glycosylation, and sialylation, and these were used for the markers of glycosylation process in the morphogenesis of HBsAg. Transmission and immunoelectron microscopic observations were used to identify the subcellular localization of HBsAg and HBsAg particle formation. Biochemical and morphological results were used to construct a model for morphogenesis of HBsAg particles. HBsAg was synthesized as 26K protein in the rough endoplasmic reticulum (ER) and then the high mannose glycan was added to form 30K protein. Three kinds of dimers with disulfide bonds 26K-26K, 26K-30K, and 30K-30K, were transported into the cytoplasmic vacuoles of the cis Golgi area. HBsAg particles were formed by the assembly of HBsAg in the cytoplasmic vacuoles and were not formed by budding or extrusion of transmemrane precursor containing HBsAg into the lumen of the ER.HBsAg particles in the vacuoles were further processed by glycosylation enzymes in the Golgi apparatus during transport to the cell surface by the cytoplasmic vacuolar flow ; conversion from the high mannose glycan to the complex type glycan, O-linked glycosylation, and sialylation in both glycans. Then fully processed HBsAg particles composed of 30K-30K, 30K-35K, and 35K-35K dimers were secreted into extracellular space possibly by exocytosis. Thus HBsAg particles expressed by VZV had novel features in its morphogenesis and glycosylation.
期刊论文(44)
专著(0)
科研奖励(0)
会议论文
Matsui,S.,Okuno,T.,Shiraki,K.: "Functional roles of terminal glycomoities in varicella-zoster virus infection." Virology. 198. 50-58 (1994)
Matsui,S.,Okuno,T.,Shiraki,K.:“末端糖基在水痘带状疱疹病毒感染中的功能作用。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
白木 公康: "B型肝炎生ワクチンの開発" 日本臨牀. 51. 241-247 (1993)
Kimiyasu Shiraki:“乙型肝炎活疫苗的开发”Nippon Rinsho,51. 241-247 (1993)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Shiraki,K.,Matsui,S.,Aiba,N.: "Susceptibility of Oka varicella vaccine strain to antiviral drugs." Vaccine. 11. 1380-1382 (1993)
Shiraki,K.、Matsui,S.、Aiba,N.:“冈水痘疫苗株对抗病毒药物的敏感性。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
白木公康: "リコンビナント水痘生ワクチンによるB型肝炎の予防" Biomedica. 7. 1425-1429 (1992)
Kimiyasu Shiraki:“通过重组水痘活疫苗预防乙型肝炎”Biomedica 7. 1425-1429 (1992)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
14
    Varicella-zoster virus IE62 immunologically cross-reacts with Brain-derived nerve growth factor and causes allodynia of herpes zoster
    • 批准号:
      22600003
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.91万
    • 财政年份:
      2010
    • 负责人:
      SHIRAKI Kimiyasu
    • 依托单位:
    Natural defense of feto-maternal infection by tropism of herpes simplex virus
    • 批准号:
      19590471
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.91万
    • 财政年份:
      2007
    • 负责人:
      SHIRAKI Kimiyasu
    • 依托单位:
    Development of attenuated herpes simplex virus vector for analysis of neurological functions.
    海外基金